Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glial grafting for demyelinating disease.

V Tepavcević1, W F Blakemore

  • 1Department of Veterinary Medicine, MS Society Cambridge Centre for Myelin Repair, Cambridge Centre for Brain Repair, UK. vanja.tepavcevic@chups.jussieu.fr

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|September 9, 2005
PubMed
Summary

Transplanting oligodendrocyte progenitor cells can remyelinate central nervous system (CNS) axons, but graft survival and rejection in multiple sclerosis treatment require further study. Enhancing allogeneic cell survival and understanding immune responses are key for effective myelin repair.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remyelination of Demyelinated CNS Axons by Transplanted Human Schwann Cells: The Deleterious Effect of Contaminating Fibroblasts.

Cell transplantation·2017
Same author

SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.

Glia·2013
Same author

A novel movement disorder in related male Labrador Retrievers characterized by extreme generalized muscular stiffness.

Journal of veterinary internal medicine·2011
Same author

The effect of injection technique on the passive spread of astrocytes following transplantation into rat spinal cord white matter.

Restorative neurology and neuroscience·2011
Same author

Effects of direct transplantation of multipotent mesenchymal stromal/stem cells into the demyelinated spinal cord.

Cell transplantation·2008
Same author

Remyelination protects axons from demyelination-associated axon degeneration.

Brain : a journal of neurology·2008

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • Remyelination of demyelinated axons in the central nervous system (CNS) offers a potential therapeutic strategy for multiple sclerosis.
  • Previous studies achieved remyelination via cell transplantation but overlooked tissue-type matching and graft rejection.
  • Allogeneic cell transplantation requires understanding immune responses for successful graft survival and CNS repair.

Purpose of the Study:

  • To investigate factors influencing the survival of allogeneic oligodendrocyte lineage cells for remyelination.
  • To evaluate the contribution of transplanted cells to remyelinating demyelinating CNS lesions.
  • To explore the impact of glial graft rejection on host remyelination and myelin repair.

Main Methods:

Related Experiment Videos

  • Review of existing literature on oligodendrocyte lineage cell transplantation and CNS immune responses.
  • Discussion of CNS immune privilege and its implications for allogeneic grafts.
  • Analysis of experimental models suitable for studying graft rejection in demyelination.

    • Main Results:

    • Allogeneic oligodendrocyte lineage cells can contribute to remyelination, but their survival is influenced by immune factors.
    • Graft rejection can occur, and the CNS inflammatory response may impact host remyelination.
    • Strategies to enhance allogeneic oligodendrocyte-mediated remyelination need further investigation.

    Conclusions:

    • Successful remyelination using allogeneic cells depends on overcoming immune rejection and optimizing cell survival.
    • The CNS immune environment plays a critical role in graft integration and myelin repair.
    • Understanding graft rejection dynamics may reveal novel therapeutic approaches for multiple sclerosis.